載入...
IMMU-39. FIRST-IN-KIND T CELLS CARRYING A CHIMERIC ANTIGEN RECEPTOR AGAINST AN EXTRACELLULAR MATRIX PROTEIN TARGET GLIOBLASTOMA CELLS AND SHOW ANTI-TUMOR EFFICACY
Immunotherapies using engineered T lymphocytes expressing chimeric antigen receptors (CAR-T cells) are showing great promise against glioblastoma but are still limited by the escape of antigen-deficient clones and by inefficient latching of the T cells to target cells surrounded by extracellular mat...
Na minha lista:
| 發表在: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216372/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.542 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|